Clinical Trials for Patients with Systemic Lupus Erythematosus

By |

PROTOCOL BMS IM026-024 A Phase 2, Multicenter, Randomized, Double-
blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of
Afimetoran in Participants With Active Systemic Lupus Erythematosus website:

Study website:

PROTOCOL RC18001 A Multicenter, Randomized, Double-Blind, Placebo-
Controlled, 2-Stage Trial to Evaluate Efficacy and Safety of Telitacicept
Compared to Placebo in Patients With Moderately to Severely Active Systemic Lupus Erythematosus website

St Paul Rheumatology